Ivan Spasojevic Selected Research

Disulfiram (Antabuse)

1/2022

Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan Spasojevic Research Topics

Disease

54	Neoplasms (Cancer) 05/2024 - 09/2002
13	Glioma (Gliomas) 01/2021 - 02/2011
8	Hyperthermia 01/2020 - 07/2006
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2007
6	Brain Neoplasms (Brain Tumor) 01/2021 - 09/2011
5	Hypoxia (Hypoxemia) 03/2023 - 10/2009
5	Glioblastoma (Glioblastoma Multiforme) 06/2020 - 01/2015
5	Colonic Neoplasms (Colon Cancer) 01/2020 - 06/2011
4	Wounds and Injuries (Trauma) 01/2021 - 04/2011
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 11/2015
4	Radiation Injuries (Radiation Sickness) 03/2018 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2016 - 10/2009
3	Ischemic Stroke 10/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 06/2010
3	Carcinogenesis 10/2021 - 05/2012
2	Carcinoma (Carcinomatosis) 03/2024 - 01/2021
2	Ischemia 10/2023 - 01/2021
2	Stroke (Strokes) 10/2023 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2012
2	Obesity 06/2021 - 09/2012
2	Hypotension (Low Blood Pressure) 01/2020 - 05/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 06/2011
2	Fibrosis (Cirrhosis) 03/2018 - 01/2017
2	Ependymoma 07/2017 - 01/2017
2	Diffuse Intrinsic Pontine Glioma 07/2017 - 01/2015
2	Neuroblastoma 07/2017 - 01/2017
2	Medulloblastoma 07/2017 - 01/2017
2	Inflammation (Inflammations) 01/2016 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 09/2015 - 06/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2012 - 08/2008
2	Spinal Cord Compression 08/2004 - 05/2004
1	Uveal melanoma 05/2024
1	Infections 10/2022

Drug/Important Bio-Agent (IBA)

21	PorphyrinsIBA 10/2023 - 10/2005
10	ManganeseIBA 10/2023 - 08/2004
10	Superoxide DismutaseIBA 03/2023 - 10/2005
9	AntioxidantsIBA 01/2016 - 08/2004
8	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 07/2006
8	EnzymesIBA 03/2023 - 01/2009
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
6	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 01/2016
6	Peptides (Polypeptides)IBA 01/2023 - 08/2015
6	alpha-hydroxyglutarateIBA 10/2019 - 02/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 10/2012
5	F2-Isoprostanes (F2 Isoprostanes)IBA 06/2021 - 01/2012
5	Niclosamide FDA Link 01/2020 - 06/2011
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 02/2011
4	Oxidoreductases (Dehydrogenase)IBA 10/2019 - 01/2009
4	CateninsIBA 11/2018 - 06/2011
4	NADP (NADPH)IBA 08/2014 - 02/2011
3	manganese(III) porphyrinIBA 07/2023 - 08/2004
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 10/2016
3	epidermal growth factor receptor VIIIIBA 06/2020 - 01/2019
3	hydroxide ionIBA 01/2020 - 07/2007
3	isocitric acid (isocitrate)IBA 10/2019 - 02/2011
3	MetalsIBA 12/2018 - 11/2014
3	Glutathione (Reduced Glutathione)IBA 11/2018 - 01/2009
3	Mn(III) meso- tetrakis(N- n- butoxyethylpyridinium- 2- yl)porphyrinIBA 01/2016 - 01/2015
3	Liposomes (Liposome)IBA 01/2010 - 07/2006
2	Superoxides (Superoxide)IBA 03/2023 - 01/2009
2	Mn(III) ortho- tetrakis(N- hexylpyridinium- 2- yl)porphyrinIBA 11/2022 - 03/2018
2	Glutathione PeroxidaseIBA 01/2022 - 11/2018
2	PlatinumIBA 01/2022 - 01/2022
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 01/2009
2	Adenosine (Adenocard)FDA LinkGeneric 10/2021 - 10/2012
2	manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrinIBA 01/2021 - 11/2018
2	Therapeutic UsesIBA 01/2021 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 06/2020 - 01/2020
2	Albumin-Bound Paclitaxel FDA Link 01/2020 - 08/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 10/2009
2	Free RadicalsIBA 03/2018 - 06/2010
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 02/2011
2	AnthelminticsIBA 08/2017 - 09/2015
2	perifosineIBA 07/2017 - 01/2017
2	dipinacoline glutamateIBA 07/2017 - 01/2017
2	CathepsinsIBA 01/2017 - 11/2015
2	mitoquinoneIBA 01/2016 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 06/2010
2	AEOL 10150IBA 09/2011 - 08/2004
2	Peroxynitrous Acid (Peroxynitrite)IBA 04/2011 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010 - 10/2009
2	liposomal doxorubicin (Doxil)FDA Link 06/2010 - 11/2006
2	fludarabineIBA 08/2008 - 12/2007
2	CytokinesIBA 10/2005 - 09/2002
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2024
1	Carboplatin (JM8)FDA LinkGeneric 03/2024
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	POEGMAIBA 01/2023
1	PolymersIBA 01/2023
1	Cefazolin (Ancef)FDA LinkGeneric 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022

Therapy/Procedure

23	Therapeutics 10/2023 - 08/2004
9	Drug Therapy (Chemotherapy) 03/2024 - 10/2009
8	Radiotherapy 01/2021 - 09/2002
2	Castration 01/2022 - 10/2016
1	Immunotherapy 05/2024
1	Thrombectomy 10/2023
1	Injections 01/2023